Role of intrathymic rat class II+ cells in maintaining deletional tolerance in xenogeneic rat→mouse bone marrow chimeras

Transplantation

Volumn 65, Issue 9, 1998, Pages 1216-1224

  Nikolic, Boris ^a   Lei, Han ^a   Pearson, Denise A ^a   Sergio, Justin J ^a   Swenson, Kirsten G ^a   Sykes, Megan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN TRANSPLANTATION; T LYMPHOCYTE; XENOTRANSPLANTATION;

ANIMALS; BONE MARROW; BONE MARROW TRANSPLANTATION; CHIMERA; CLONAL DELETION; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNE TOLERANCE; MICE; MICE, INBRED STRAINS; RATS; RATS, INBRED STRAINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES; THYMUS GLAND; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032525147     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199805150-00013     Document Type: Article

References (38)

1. Auchincloss HA. Why is cell-mediated xenograft rejection so strong? Xeno 1995; 3: 19.
2. Sharabi Y, Aksentijevich I, Sundt TM III, Sachs DH, Sykes M. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med 1990; 172: 195.
3. Tomita Y, Lee LA, Sykes M. Engraftment of rat bone marrow and its role in negative selection of murine T cells in mice conditioned with a modified non-myeloablative regimen. Xenotransplantation 1994; 1: 109.
4. Tomita Y, Khan A, Sykes M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a non-myeloablative regimen. J Immunol 1994; 153: 1087.
5. Lee LA, Sergio JJ, Sachs DH, Sykes M. Mechanism of tolerance in mixed xenogeneic chimeras prepared with a non-myeloablative conditioning regimen. Transplant Proc 1994; 26: 1197.
6. Gritsch HA, Sykes M. Host marrow has a competitive advantage which limits donor hematopoietic repopulation in mixed xenogeneic chimeras. Xenotransplantation 1996; 3: 312.
7. Sykes M, Romick ML, Hoyles KA, Sachs DH. In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment. J Exp Med 1990; 171: 645.
8. Dialynas DP, Quan ZS, Wall KA, et al. Characterization of murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to human Leu3/T4 molecule. J Immunol 1983; 131: 2445.
9. Sarmiento M, Glasebrook AL, Fitch FW. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt2 antigen block T cell-mediated cytolysis in the absence of complement. J Immunol 1980; 125: 2665.
10. Ledbetter JA, Herzenberg LA. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 1979; 47: 63.
11. Koo GC, Peppard JR. Establishment of monoclonal anti-NK-1.1 antibody. Hybridoma 1984; 3: 301.
12. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen. J Exp Med 1989; 169: 493.
13. Matsuura A, Ishii Y, Yuasa H, et al. Rat T lymphocyte antigens comparable with mouse Lyt-1 and Lyt-2,3 antigenic systems: characterization by monoclonal antibodies. J Immunol 1984; 132: 316.
14. Sherman LA, Randolph CP. Monoclonal anti-H-2Kb antibodies detect serological differences between H-2Kb mutants. Immunogenetics 1981; 12: 183.
15. Unkeless JC. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med 1979; 150: 580.
16. Tomita Y, Khan A, Sykes M. Mechanism by which additional monoclonal antibody injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mAbs and 3 Gy whole body irradiation. Transplantation 1996; 61: 477.
17. Ozato K, Sachs DH. Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression. J Immunol 1981; 126: 317.
18. Lee LA, Gritsch HA, Sergio JJ, et al. Specific tolerance across a discordant xenogeneic transplantation barrier. Proc Natl Acad Sci USA 1994; 91: 10864.
19. Tomita Y, Nishimura Y, Harada N, et al. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion. J Immunol 1990; 145: 4026.
20. Acha-Orbea H, Palmer E. Mls-a retrovirus exploits the immune system. Immunol Today 1991; 12: 356.
21. Tomonari K, Fairchild S. The genetic basis of negative selection of TCR Vβ11+ T cells. Immunogenetics 1991; 33: 157.
22. Theobald M, Bunjes D. Pretransplant detection of human minor histocompatibility antigen-specific naive and memory interleukin-2-secreting T cells within class I major histocompatibility complex (MHC)-restricted CD8+ and class II MHC-restricted CD4+ T cell subsets. Blood 1993; 82: 298.
23. Lee LA, Sergio JJ, Sykes M. Evidence for non-immune mechanisms in the loss of hematopoietic chimerism in rat→mouse mixed xenogeneic chimeras. Xenotransplantation 1995; 2: 57.
24. Marrack P, Lo D, Brinster R, et al. The effect of thymus environment on T cell development and tolerance. Cell 1988; 53: 627.
25. Ramsdell F, Fowlkes BJ. Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance. Science 1990; 248: 1342.
26. Schonrich G, Strauss G, Muller K-P, et al. Distinct requirements of positive and negative selection for selecting cell type and CD8 interaction. J Immunol 1993; 151: 4098.
27. Diamond AG, Hood LE, Howard JC, Windle M, Winoto A. The class II genes of the rat MHC. J Immunol 1989; 142: 3268.
28. Shinohara N, Sachs DH. Evidence for homologues of the murine I-A and I-E loci in the rat MHC. J Immunol 1981; 126: 934.
29. Figueroa F, Klein J The evolution of MHC class II genes. Immunol Today 1986; 7: 78.
30. Surh CD, Sprent J. Long-term xenogeneic chimeras: full differentiation of rat T and B cells in SCID mice. J Immunol 1991; 147: 2148.
31. Surh CD, Gold PD, Wiley S, Wilson DB, Sprent J. Rat T cell response to superantigens. I. Vβ-restricted clonal deletion of rat T cells differentiating in rat to mouse chimeras. J Exp Med 1994; 179: 57.
32. Gold PD, Surh CD, Sellins KS, Schroder K, Sprent J, Wilson DB. Rat T cell responses to superantigens. II. Allelic differences in Vβ8.2 and Vβ8.5 β chains determine responsiveness to staphylococcal enteroxin B and mouse mammary tumor virus-encoded products. J Exp Med 1994; 179: 63.
33. Starzl TE, Demetris AJ, Trucco M, et al. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 1993; 55: 1272.
34. Starzl TE, Murase N, Thomson A, Demetris AJ. Liver transplants contribute to their own success. Nat Med 1996; 163.
35. Sharabi Y, Abraham VS, Sykes M, Sachs DH. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance. Bone Marrow Transplant 1992; 9: 191.
36. Khan A, Tomita Y, Sykes M. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Transplantation 1995; 62: 380.
37. Aksentijevich I, Sachs DH, Sykes M. Humoral tolerance in xenogeneic BMT recipients conditioned with a non-myeloablative regimen. Transplantation 1992; 53: 1108.
38. Nikolic B, Sykes M. Clonal deletion as a mechanism of transplantation tolerance. J Heart Lung Transplant 1996; 15: 1171.